bluebird bio Inc
(NAS:BLUE)
$
0.7089
0.0118 (1.71%)
Market Cap: 135.01 Mil
Enterprise Value: 262.15 Mil
PE Ratio: 0
PB Ratio: 0.34
GF Score: 25/100 bluebird bio Inc (BLUE) Transcripts
- Q2 2024 bluebird bio Inc Earnings Call TranscriptAug 14, 2024$0.8149 (-23.12%)Earnings
- Q4 2023 bluebird bio Inc Earnings Call TranscriptMar 26, 2024$1.2 (-11.76%)Earnings
- bluebird bio Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 bluebird bio Inc Earnings Call TranscriptNov 07, 2023$3.54 (+7.27%)Earnings
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 bluebird bio Inc Earnings Call TranscriptAug 08, 2023$3.89 (+8.06%)Earnings
- bluebird bio Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- bluebird bio Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q4 2022 bluebird bio Inc Earnings Call TranscriptMar 29, 2023$3.26 (-24.54%)Earnings
- bluebird bio Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- bluebird bio Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- bluebird bio Inc Receives FDA Accelerated Approval for SKYSONA Call TranscriptSep 19, 2022
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- bluebird bio Inc Launch Call TranscriptAug 18, 2022
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- bluebird bio Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- bluebird bio Inc Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US Investor Call TranscriptApr 05, 2022
- bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- bluebird bio Inc Spotlight on bb1111 for Sickle Cell Disease Conference Call TranscriptNov 18, 2021
- bluebird bio Inc at Bank of America Global Healthcare Conference (Virtual) TranscriptSep 16, 2021
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- bluebird bio Inc at Wedbush PacGrow Healthcare Conference (Virtual) TranscriptAug 11, 2021
- Q2 2021 bluebird bio Inc Earnings Call TranscriptAug 09, 2021$11.76 (-27.45%)Earnings
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- bluebird bio Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- bluebird bio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- bluebird bio Inc to Provide Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program - Conference Call TranscriptMar 10, 2021
- bluebird bio Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- bluebird bio Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- bluebird bio Inc Temporary Suspension On Phase 1/2 And Phase 3 Studies Of LentiGlobin Gene Therapy For Sickle Cell Disease (bb1111) Corporate Call TranscriptFeb 16, 2021
- bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- bluebird bio Inc to Separate Oncology Business into Independent Company Conference Call TranscriptJan 11, 2021
- bluebird bio Inc ASH Data Review Conference Call TranscriptDec 08, 2020
- bluebird bio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- bluebird bio Inc at Cowen Immuno-Oncology Next Summit TranscriptNov 13, 2020
- Q3 2020 bluebird bio Inc Earnings Call TranscriptNov 04, 2020$37.9 (+7.33%)Earnings
- bluebird bio Inc at Jefferies Cell Therapy Summit TranscriptOct 06, 2020
- bluebird bio Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- bluebird bio Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2020
- bluebird bio Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 12, 2020
- bluebird bio Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- bluebird bio Inc EHA Data Review - Call TranscriptJun 12, 2020
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- bluebird bio Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- bluebird bio Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Q1 2020 bluebird bio Inc Earnings Call TranscriptMay 11, 2020$38.99 (+1.60%)Earnings
- bluebird bio Inc Provides Assessment of Impact of COVID-19 - Call TranscriptMar 26, 2020
- bluebird bio Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- bluebird bio Inc at Leerink Global Healthcare Conference TranscriptFeb 26, 2020
- bluebird bio Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- bluebird bio Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- bluebird bio Inc American Society of Hematology (ASH) Data Review - Call TranscriptDec 10, 2019
- bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa TranscriptOct 02, 2019
- bluebird bio Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- bluebird bio Inc at Citi Biotech Conference TranscriptSep 04, 2019
- bluebird bio Inc to Present New Data at the European Hematology Association (EHA) Congress Conference Call TranscriptJun 14, 2019
- bluebird bio Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- bluebird bio Inc at Jefferies Healthcare Conference TranscriptJun 04, 2019
- bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- bluebird bio Inc Analyst Day TranscriptMay 09, 2019
- bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean - PLENARY SESSION: COMMERCIAL STRATEGIES FROM PATHFINDERS IN THE INDUSTRY TranscriptApr 23, 2019
- bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day TranscriptMar 21, 2019
- bluebird bio Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- bluebird bio Inc at Cowen Health Care Conference TranscriptMar 12, 2019
- 1